CompoAtlas

B12

Food supplement declared in France, declaration No 2020-2-223

B12 (Vimergy) is a food supplement declared in France. Status: retiré du marché le 1 November 2023. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Vimergy
Food business operator placing the product on the market
LAWRENCE GENEVIEVE
Status
Retiré du marché le 1 November 2023
Form
Flacon
Daily dose
5mg
Directions for use
Prendre 1 compte goutte et garder sous la langue pendant 20 secs avant d’avaler 1 à 2 fois par jour
Objectives stated by the manufacturer (these are not authorised claims)
Système nerveux

Declaration 300312, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
MéthylcobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
5'-déoxyadénosylcobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011

Additives

E422

Other ingredients

Eau purifiée

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Consultez votre médecin avant d'utiliser ce produit si vous êtes enceinte, si vous allaitez, si vous avez un problème médical ou si vous prenez des médicaments.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Vimergy

Enter to analyse, Shift+Enter for a new line